SCOPUS 정보 검색 플랫폼

Volumn 86, Issue 2, 2001, Pages 611-615

Effect of melagatran on prothrombin time assays depends on the sensitivity of the thromboplastin and the final dilution of the plasma sample

(4) Mattsson, C a Menschiek Lundin, A a Wahlander K a Lindahl, T L a

a ASTRAZENECA R AND D (Sweden)

Author keywords

Anticoagulants; Direct thrombin inhibitors; Melagatran; Prothrombin time; Thromboplastin

Indexed keywords

ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 7; MELAGATRAN; PROTHROMBIN; REAGENT; RECOMBINANT THROMBOPLASTIN; THROMBIN INHIBITOR; THROMBOPLASTIN; THROMBOPLASTIN S; TROMBOPLASTIN HS; UNCLASSIFIED DRUG; VITAMIN K GROUP; WARFARIN;

ARTICLE; ASSAY; ASSOCIATION; BIOMEDICAL TECHNOLOGY ASSESSMENT; BLOOD CLOTTING; BLOOD SAMPLING; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIAGNOSTIC VALUE; DILUTION; DOSE CALCULATION; DOSE RESPONSE; DRUG INHIBITION; DRUG MONITORING; FEMALE; HUMAN; HUMAN CELL; IC 50; LABORATORY TEST; MALE; NORMAL HUMAN; NORMAL VALUE; PLASMA CHARACTERISTICS; PRIORITY JOURNAL; PROTHROMBIN TIME; QUANTITATIVE ASSAY; RECEPTOR SENSITIVITY; SENSITIVITY AND SPECIFICITY; STANDARDIZATION;

EID: 0034898310 PISSN: 03406245 EISSN: None Source Type: Journal
DOI: 10.1055/s-0037-1616094 Document Type: Article

Times cited : (36)

References (10)

1
- 0000333461
- A study of the coagulation defect in hemophilia and in jaundice
- (1935) Am J Med Sci , vol.190 , pp. 510-511
- Quick, A.J.¹ Stanley-Brown, M.² Bancroft, F.W.³

2
- 0003084625
- Study of some variables affecting the prothrombin time
- (1938) Proc Soc Exp Biol Med , vol.38 , pp. 11-16
- Aggeler, P.M.¹ Lucia, S.P.²

3
- 0001443323
- Standardization of the quick prothrombin test
- (1946) Blood , vol.1 , pp. 220-233
- Aggeler, P.M.¹ Howard, J.² Lucia, S.³ Clark, W.⁴ Astaff, A.⁵

4
- 78651029269
- The control of dicumarol therapy and the quantitative determination of prothrombin and proconvertin
- (1951) Scand J Clin Lab Invest , vol.3 , pp. 201-208
- Owren, P.A.¹ Aas, K.²

5
- 49749212311
- Thrombotest. A new method for controlling anticoagulant therapy
- (1959) Lancet , vol.2 , pp. 754-758
- Owren, P.A.¹

6
- 0031984477
- Effects of melagatran, a new low molecular weight thrombin inhibitor, on thrombin and fibrinolytic enzymes
- (1998) Thromb Haemost , vol.79 , pp. 110-118
- Gustafsson, D.¹ Antonsson, T.² Bylund, R.³ Eriksson, U.⁴ Gyzander, E.⁵ Nilsson, I.⁶ Ekg, M.⁷ Mattsson, C.⁸ Deinum, J.⁹ Persson, S.¹⁰ Larlsson, O.¹¹ Nilsson, A.¹² Sörensen, H.¹³

7
- 0343484317
- Conjectures and refutations on the mode of action of heparins
- (1999) Haemostasis , vol.29 , pp. 170-178
- Beguin, S.¹ Welzel, D.² Al Dieri, R.³ Hemker, H.C.⁴

8
- 0033008172
- Pharmacokinetics and pharmacodynamics of melagatran, a novel synthetic LMW thrombin inhibitor, in patients with acute DVT
- (1999) Thromb Haemost , vol.81 , pp. 358-363
- Eriksson, H.¹ Eriksson, U.G.² Frison, L.³ Hansson, P.O.⁴ Held, P.⁵ Holmström, M.⁶ Hägg, A.⁷ Johnsson, T.⁸ Lapidus, L.⁹ Leijd, B.¹⁰ Stockelberg, D.¹¹ Säfwenberg, U.¹² Taghavi, A.¹³ Thorsen, M.¹⁴

9
- 0033135457
- Antithrombotic effects and bleeding time of thrombin inhibitors and warfarin in the rat
- (1999) Thromb Res , vol.94 , pp. 187-197
- Elg, M.¹ Gustafsson, D.² Carlsson, S.³

10
- 0017044123
- Anticoagulant properties of heparin fractionated by affinity chromatography on matrix-bound antithrombin and by gel filtration
- (1976) Thromb Res , vol.9 , pp. 575-583
- Andersson, L.-O.¹ Barrowcliffe, T.W.² Holmer, E.³ Johnson, E.A.⁴ Sims, G.E.C.⁵

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.